Quick summary: Heartmate II™ and Heartmate 3™ Left Ventricular Assist Systems. Date: 2024-03-06.
Heartmate II™ and Heartmate 3™ Left Ventricular Assist Systems
2024-03-06
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Heartmate II™ and Heartmate 3™ Left Ventricular Assist Systems. Date: 2024-03-06.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Abbott is notifying customers of a planned update to instructions for use associated with observed outflow graft deformation known as "extrinsic outflow graft obstruction" (EOGO) associated with the Heartmate 3™ left ventricular assist system (LVAS) and Heartmate II™ LVAS. Significant EOGO will manifest clinically as as a persistent low flow alarm under certain circumstances in some patients, and in such cases, may impair the ability of the Heartmate LVAS to provide adequate hemodynamic support. Recall start date: February 20, 2024
What you should do
- Contact the manufacturer if you require additional information .
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.